Correction to the role of Apolipoprotein E4 allele in the gut microbiome of Puerto Ricans with Alzheimer’s disease

by Clinical Neuropsychologist | Saturday, March 30, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 30, 2024 Wiley: Alzheimer’s & Dementia: Table...

Histories of neighborhood socioeconomic status contribute to race differences in later‐life cognition

by Clinical Neuropsychologist | Saturday, March 30, 2024 | Dementia

Abstract INTRODUCTION Neighborhood characteristics are increasingly implicated in cognitive health disparities, but no research has investigated how the historical context of neighborhoods shapes these disparities. METHODS Four hundred sixty-four Black (55%) and White...

Meaningful co-production to bring meaningful change: Developing the Allied Health Professionals Dementia Framework for Wales together

by Clinical Neuropsychologist | Thursday, March 28, 2024 | Dementia

Dementia, Volume 23, Issue 5, Page 724-740, July 2024. In line with increasing participatory approaches to service and research design, there is a growing appreciation of the need to understand the lived experience of people accessing care and support, including...

Self-report instruments measuring aspects of self for people living with dementia: A systematic literature review of psychosocial interventions

by Clinical Neuropsychologist | Thursday, March 28, 2024 | Dementia

Dementia, Volume 23, Issue 4, Page 669-702, May 2024. ObjectiveA positive sense of self may be a key domain of psychological well-being for people living with dementia and therefore a legitimate target for psychosocial interventions in dementia care. Determining the...

Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD‐risk‐enriched cohorts

by Clinical Neuropsychologist | Thursday, March 28, 2024 | Dementia

Abstract INTRODUCTION Published norms are typically cross-sectional and often are not sensitive to preclinical cognitive changes due to dementia. We developed and validated demographically adjusted cross-sectional and longitudinal normative standards using harmonized...

Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort

by Clinical Neuropsychologist | Thursday, March 28, 2024 | Dementia

Abstract INTRODUCTION Lewy body disease (LBD) is a common primary or co-pathology in neurodegenerative syndromes. An alpha-synuclein seed amplification assay (αSyn-SAA) is clinically available, but clinical performance, especially lower sensitivity in...